Latest News:

Tufts CSDD Demonstrates Multi-Million-Dollar Benefits of Translational Pharmaceutics®

Quotient Clinical hosts formulation development and drug delivery seminar series

18th June 2016

Formulation Design

Quotient Sciences, the Translational Pharmaceutics® company, is holding a series of formulation development and drug delivery seminars this June and July. The seminars will take place at major life science hubs in the UK and USA, and will address the most pressing challenges currently faced by pharmaceutical and biotechnology companies in early drug development.

Starting in San Diego, the series will bring together a team of industry experts for insightful presentations and discussions, giving attendees the chance to explore innovative approaches for optimizing drug product formulations; from strategies and technologies to enhance oral bioavailability to the use of spray drying to overcome solubility challenges.

Speakers include prominent biotech consultant and entrepreneur Nick Barker and Richard Johnson, CEO and Founder of Upperton Ltd, and they will be joined by representatives from Quotient Clinical’s experienced scientific team, including John McDermott, Dr Kieran Crowley and Dr Kevin Kane. The presentations and discussions will be followed by a complimentary lunch, providing an informal networking opportunity to further examine these issues with leading industry figures.

Download a PDF version of the press release

For further information, please contact:

Robin Bodicoat
Marketing Director
Quotient Clinical
Tel: +44 (0)115 931 5102
robin.bodicoat@quotientclinical.com

News

Read related news

Ask us a question

We use cookies to help us to improve our site and enables us to the best possible service and customer experience. By clicking accept you are agreeing to let us share your data with select third parties for analytics and marketing purposes.